Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

PURPOSE: The third- or later-line therapy available often yield poor survival benefit in patients metastatic colorectal cancer (mCRC). The retrospective study aimed to evaluate efficacy of rechallenge of oxaliplatin-containing regimens. PATIENTS AND METHODS: Patients with mCRC who progressed from fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiong, Huang, Yuanyuan, Jiang, Zhimin, Wang, Huizhong, Li, Weiyu, Zhang, Bei, Xie, Derong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937494/
https://www.ncbi.nlm.nih.gov/pubmed/29760556
http://dx.doi.org/10.2147/OTT.S154220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937494/
https://www.ncbi.nlm.nih.gov/pubmed/29760556
http://dx.doi.org/10.2147/OTT.S154220

Ejemplares similares